ZIMMER BIOMET HOLDINGS, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
ZIMMER BIOMET HOLDINGS, INC. (ZBH) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $41.20 million as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-02-20
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $41.20M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $42.20M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $44.40M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $36.60M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed |
|---|---|---|
| 2025-12-31 | $41.20M 10-K · filed 2026-02-20 | |
| 2024-12-31 | $42.20M 10-K · filed 2026-02-20 | |
| 2023-12-31 | $44.40M 10-K · filed 2025-02-25 | |
| 2022-12-31 | $36.60M 8-K · filed 2024-08-07 | |
| 2021-12-31 | $30.20M 10-K · filed 2023-02-24 | $32.60M 10-K · filed 2022-02-25 |
| 2020-12-31 | $28.70M 8-K · filed 2022-06-22 | $30.40M 10-K · filed 2021-02-22 |
| 2019-12-31 | $28.60M 10-K · filed 2021-02-22 | |
| 2018-12-31 | $27.30M 10-K · filed 2020-02-21 | |
| 2017-12-31 | $26.80M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $60.30M 10-K · filed 2018-02-27 | |
| 2015-12-31 | $59.00M 10-K · filed 2017-03-01 | |
| 2014-12-31 | $59.90M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $74.60M 10-K · filed 2015-02-23 | |
| 2012-12-31 | $106.30M 10-K · filed 2014-02-28 | |
| 2011-12-31 | $98.30M 10-K · filed 2013-02-27 | |
| 2010-12-31 | $85.40M 10-K · filed 2012-02-27 | |
| 2009-12-31 | $71.10M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |